Log in to save to my catalogue

Plasma microRNAs to Select Optimal Patients for Antibody Production from Anti-Addiction Vaccines

Plasma microRNAs to Select Optimal Patients for Antibody Production from Anti-Addiction Vaccines

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_64e1c6e04b4b43c9ac28d05ff441ab1e

Plasma microRNAs to Select Optimal Patients for Antibody Production from Anti-Addiction Vaccines

About this item

Full title

Plasma microRNAs to Select Optimal Patients for Antibody Production from Anti-Addiction Vaccines

Publisher

Switzerland: MDPI AG

Journal title

Vaccines (Basel), 2025-02, Vol.13 (2), p.181

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

: Cocaine and illicit amphetamines (disguised as "Adderall") are being laced with fentanyl and producing accidental and intentional fatal overdoses. Vaccines can prevent these overdoses, but 33% of humans generate insufficient anti-drug antibody (AB) levels. Plasma microRNAs (miRs) can be used to predict non-responders. We have plasma stored from 1...

Alternative Titles

Full title

Plasma microRNAs to Select Optimal Patients for Antibody Production from Anti-Addiction Vaccines

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_64e1c6e04b4b43c9ac28d05ff441ab1e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_64e1c6e04b4b43c9ac28d05ff441ab1e

Other Identifiers

ISSN

2076-393X

E-ISSN

2076-393X

DOI

10.3390/vaccines13020181

How to access this item